Details of the Drug

General Information of Drug (ID: DMTIRKH)

Drug Name

PEC-Encap

Indication

Disease Entry	ICD 11	Status	REF
Type-1 diabetes	5A10	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04678557) An Open-Label Phase 1/2 Study to Evaluate the Safety, Engraftment, and Efficacy of VC-01?Combination Product in Subjects With Type 1 Diabetes Mellitus [T1DM]. U.S.National Institutes of Health.